Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats

Metabolism: Clinical and Experimental

Volumn 45, Issue 6, 1996, Pages 680-685

  Hoogerbrugge, Nicoline ^a   Jansen, Hans ^a   Staels, Bart ^a   Kloet, Lianne T ^a   Birkenhäger, Jan C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GROWTH HORMONE DEFICIENCY; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; THYROID HORMONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029976637     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90131-6     Document Type: Article

References (39)

1. Walton KW, Scott PJ, Dykes PW, et al: The significance of alterations in serum lipids in thyroid dysfunction. Clin Sci 29:217-238, 1965
2. Dory L, Roheim PS: Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism. J Lipid Res 22:287-296, 1981
3. Sykes M, Cnoop-Koopmans WM, Julien P, et al: The effects of hypothyroidism, age and nutrition in the rat. Metabolism 30:733-738, 1981
4. Gross G, Syke M, Arellano R, et al: HDL clearance and receptor-mediated catabolism of LDL are reduced in hypothyroid rats. Atherosclerosis 66:269-275, 1987
5. Thompson GR, Soutar AK, Spengel FA, et al: Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591-2595, 1981
6. Scarabottola L, Trezzi E, Roma P, et al: Experimental hypothyroidism modulates the expression of the LDL-receptor by the liver. Atherosclerosis 59:329-333, 1986
7. Chait A, Bierman EL, Albers JJ: Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 48:887-889, 1979
8. Katakami H, Down TR, Frohman L: Decreased hypothalamic growth hormone-releasing hormone content and pituitary responsiveness in hypothyroidism. J Clin Invest 77:11704-11711, 1986
9. Wood DF, Franklyn JA, Ramsden D, et al: The effect of thyroid hormones on growth hormone gene expression in vivo in rats. J Endocrinol 112:459-463, 1987
10. Friedman M, Byers SO, Rosenman RH, et al: Effect of subacute administration of human growth hormone on various serum lipid and hormone levels in hypercholesterolemic and normocholesterolemic subjects. Metabolism 23:905-912, 1974
11. Nikkilä EA, Pelkonen R: Serum lipids in acromegaly. Metabolism 24:829-838, 1975
12. Hoogerbrugge-van der Linden N, Jansen H, Hülsmann WC, et al: Relationship between insulin-like growth factor-I and low-density lipoprotein cholesterol levels in primary hypothyroidism in women. J Endocrinol 123:341-345, 1989
13. Byers SO, Friedman M, Rosenman RH: Prevention of hypercholesterolaemia in thyroidectomized rats by growth hormone. Nature 228:464-465, 1970
14. Hoogerbrugge-v.d. Linden N, Jansen H, Wouters NMH: Growth hormone and thyroxine affect lipoprotein metabolism in hypothyroid and hypophysectomized rats. J Endocrinol 125:403-407, 1990
15. Martin D, Epelbaum J, Bluet-Pajot M, et al: Thyroidectomy abolishes pulsatile growth hormone secretion without hypothalamic somatomedin. Neuroendocrinology 41:476-481, 1985
16. Jörgensen KD: Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Acta Endocrinol (Copenh) 114:24-131, 1987
17. Skottner A, Clark RG, Robinson ICAF, et al: Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats. J Endocrinol 112:123-132, 1987
18. Oosterom R, Verleun T, Zuyderwijk J, et al: Growth hormone secretion by cultured rat anterior pituitary cells. Effects of culture conditions and dexamethasone. Endocrinology 113:735-741, 1983
19. Zechner R, Meser R, Kostner GM: Isolation of pure LpB from human serum. J Lipid Res 27:681-686, 1986
20. McFarlane AS: Labelling of plasma proteins with radioactive iodine. Biochem J 62:135-143, 1956
21. Billheimer DW, Eisenberg S, Levy R: The metabolism of very low density lipoprotein proteins. Biochim Biophys Acta 260:212-221, 1972
22. 131I-labeled plasma proteins. Phys Med Biol 2:36-53, 1957
23. Aronson NN, Touster O: Isolation of rat liver plasma membrane fragments in isotonic sucrose. Methods Enzymol 31:90-102, 1974
24. Maggi FM, Catapano AL: A dot-blot assay for the low density lipoprotein receptor. J Lipid Res 28:108-112, 1987
25. Chirgin JM, Przybyla AE, MacDonald RJ, et al: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5297, 1979
26. Staels B, Auwerx J, Chan L, et al: Influence of development, oestrogens and food intake on apolipoprotein A-I, A-II and E mRNA in the rat liver and intestine. J Lipid Res 30:1137-1141, 1989
27. Staels B, van Tol A, Chan L, et al: Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride-lipase and LDL-receptor in rats. Endocrinology 127:1144-1152, 1990
28. Cleveland DW, Lopata MA, MacDonald RJ, et al: Number and evolutionary conservation of alpha- and β-tubulin and cytoplasmic β- and gamma-actin genes using specific cloned cDNA probes. Cell 20:958-962, 1980
29. Cooper RA: Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med 297:371-377, 1977
30. Mahley RW, Weisgraber KH, Melchior GW, et al: Inhibition of receptor-mediated clearance of lysine and arginine modifled lipoproteins from the plasma of rats and monkeys. Proc Natl Acad Sci USA 77:225-229, 1980
31. Hooft van FM, Tol van A: Sites of degradation of purified rat low density lipoprotein and high density lipoprotein in the rat. Biochim Biophys Acta 839:344-353, 1985
32. Goldstein JL, Basu SK, Brunschede GY, et al: Release of low density lipoprotein from its cell surface receptor of sulfated glucosaminoglycans. Cell 7:85-95, 1976
33. Harkes L, van Berkel THJC: Cellular localization of the receptor-dependent and receptor independent uptake of human LDL in liver of normal and 17 alpha-ethinyl estradiol treated rats. FEBS Lett 154:75-80, 1983
34. Salter AM, Bugaut M, Saxton J, et al: Effects of preincubation of primary monolayer cultures of rat hepatocytes with low- and high-density lipoproteins on subsequent binding and metabolism of human low-density lipoprotein. Biochem J 247:79-84, 1987
35. Glass CK, Holloway JM, Devary OV, et al: The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313-323, 1988
36. Ness GC: Thyroid hormone. Basis for its hypocholesterolemic effect. J Fla Med 78:383-385, 1991
37. Laron Z, Klinger B, Jensen LT, et al: Biochemical and hormonal changes induced by one week administration of rIGF-I to patients with Laron type dwarfism. Clin Endocrinol (Oxf) 35:145-150, 1991
38. Oscarsson, Lundstam U, Gustafsson B, et al: Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol (Oxf) 42:673-676, 1995
39. Rudling M, Norstedt G, Olivecrona H, et al: Importance of growth hormone for induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 1989:6983-6987, 1992